On February 14, 2018, the U.S. Food and Drug Administration (FDA) approved Janssen Therapeutics’ Erleada (apalutamide), a non-steroidal antiandrogen for... Read More
Skin cancer, colorectal cancer, prostate cancer or lymphoma sometimes occur after a heart transplant because of the immune suppressing drugs... Read More
A new study comparing the results of robot-assisted radical prostatectomy (RARP) to the current standard, open radical prostatectomy (ORP) has... Read More
A treatment for localized prostate cancer known as Intensity Modulated Radiation Therapy (IMRT) is better than conventional conformal radiation therapy... Read More
Tomorrow marks the highly anticipated release of our fourth annual Trademark Intelligence Report, offering a comprehensive analysis of the trademark... Read More